Case #1: The molecular genetic testing of the VHL mutations previously performed for the patient at another laboratory seems to be insufficiently justified, since a pathologist’s conclusion regarding the type of renal cell carcinoma was not received before testing. This evidence concerns the gene VHL and renal cell carcinoma.